

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neuron cell-cell adhesion (GO:0007158) | 5.96853903 |
| 2 | behavioral response to nicotine (GO:0035095) | 5.88604488 |
| 3 | vocalization behavior (GO:0071625) | 5.76472523 |
| 4 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.51242772 |
| 5 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.30960980 |
| 6 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.24556999 |
| 7 | locomotory exploration behavior (GO:0035641) | 5.22726020 |
| 8 | protein localization to synapse (GO:0035418) | 5.19191603 |
| 9 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.00197868 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.95310696 |
| 11 | synaptic vesicle exocytosis (GO:0016079) | 4.91543226 |
| 12 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.88197772 |
| 13 | synaptic vesicle maturation (GO:0016188) | 4.84304460 |
| 14 | exploration behavior (GO:0035640) | 4.71450502 |
| 15 | glutamate receptor signaling pathway (GO:0007215) | 4.62621325 |
| 16 | neuron recognition (GO:0008038) | 4.61901121 |
| 17 | layer formation in cerebral cortex (GO:0021819) | 4.61455279 |
| 18 | glutamate secretion (GO:0014047) | 4.59856323 |
| 19 | dendritic spine morphogenesis (GO:0060997) | 4.41307882 |
| 20 | presynaptic membrane assembly (GO:0097105) | 4.31362980 |
| 21 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.31276436 |
| 22 | axonal fasciculation (GO:0007413) | 4.29698170 |
| 23 | synaptic transmission, glutamatergic (GO:0035249) | 4.29399251 |
| 24 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.24645052 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.24510445 |
| 26 | proline transport (GO:0015824) | 4.17309584 |
| 27 | postsynaptic membrane organization (GO:0001941) | 4.16953517 |
| 28 | neuron-neuron synaptic transmission (GO:0007270) | 4.07196276 |
| 29 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.02688889 |
| 30 | neuronal action potential (GO:0019228) | 4.01781535 |
| 31 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.94669268 |
| 32 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.93028840 |
| 33 | presynaptic membrane organization (GO:0097090) | 3.88641325 |
| 34 | neurotransmitter secretion (GO:0007269) | 3.85836737 |
| 35 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.77940560 |
| 36 | dendrite morphogenesis (GO:0048813) | 3.77914528 |
| 37 | neuronal action potential propagation (GO:0019227) | 3.77451511 |
| 38 | regulation of synaptic vesicle transport (GO:1902803) | 3.76949017 |
| 39 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.74989007 |
| 40 | regulation of synapse structural plasticity (GO:0051823) | 3.74022768 |
| 41 | gamma-aminobutyric acid transport (GO:0015812) | 3.71692277 |
| 42 | membrane depolarization during action potential (GO:0086010) | 3.71002623 |
| 43 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.65494396 |
| 44 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.62724284 |
| 45 | regulation of postsynaptic membrane potential (GO:0060078) | 3.61779249 |
| 46 | long-term memory (GO:0007616) | 3.59269151 |
| 47 | transmission of nerve impulse (GO:0019226) | 3.58512169 |
| 48 | positive regulation of synapse maturation (GO:0090129) | 3.57092189 |
| 49 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.55700104 |
| 50 | positive regulation of membrane potential (GO:0045838) | 3.53972202 |
| 51 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.53280168 |
| 52 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.52384450 |
| 53 | auditory behavior (GO:0031223) | 3.47782105 |
| 54 | nucleobase catabolic process (GO:0046113) | 3.46488986 |
| 55 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.46361084 |
| 56 | establishment of mitochondrion localization (GO:0051654) | 3.38516533 |
| 57 | synapse assembly (GO:0007416) | 3.37131173 |
| 58 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33383897 |
| 59 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.33326227 |
| 60 | behavioral response to ethanol (GO:0048149) | 3.33137065 |
| 61 | startle response (GO:0001964) | 3.33022676 |
| 62 | response to histamine (GO:0034776) | 3.32067683 |
| 63 | serotonin metabolic process (GO:0042428) | 3.28657685 |
| 64 | regulation of synaptic plasticity (GO:0048167) | 3.28533342 |
| 65 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.25300342 |
| 66 | mitochondrion transport along microtubule (GO:0047497) | 3.25300342 |
| 67 | cell migration in hindbrain (GO:0021535) | 3.21871264 |
| 68 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.20636201 |
| 69 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.20212819 |
| 70 | long-term synaptic potentiation (GO:0060291) | 3.20094598 |
| 71 | response to auditory stimulus (GO:0010996) | 3.19986086 |
| 72 | primary amino compound metabolic process (GO:1901160) | 3.18586414 |
| 73 | neurotransmitter transport (GO:0006836) | 3.18085396 |
| 74 | activation of protein kinase A activity (GO:0034199) | 3.18036114 |
| 75 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.18009295 |
| 76 | behavioral fear response (GO:0001662) | 3.17305553 |
| 77 | behavioral defense response (GO:0002209) | 3.17305553 |
| 78 | innervation (GO:0060384) | 3.17128863 |
| 79 | positive regulation of synapse assembly (GO:0051965) | 3.17079746 |
| 80 | learning (GO:0007612) | 3.16767827 |
| 81 | regulation of dendritic spine development (GO:0060998) | 3.16116346 |
| 82 | cerebellar granule cell differentiation (GO:0021707) | 3.14951790 |
| 83 | protein polyglutamylation (GO:0018095) | 3.14653646 |
| 84 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.14462851 |
| 85 | organelle transport along microtubule (GO:0072384) | 3.13665604 |
| 86 | synaptic vesicle endocytosis (GO:0048488) | 3.11579025 |
| 87 | regulation of action potential (GO:0098900) | 3.11156866 |
| 88 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.09395783 |
| 89 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.08437316 |
| 90 | mechanosensory behavior (GO:0007638) | 3.07337661 |
| 91 | regulation of vesicle fusion (GO:0031338) | 3.07161149 |
| 92 | L-fucose catabolic process (GO:0042355) | 3.06891550 |
| 93 | fucose catabolic process (GO:0019317) | 3.06891550 |
| 94 | L-fucose metabolic process (GO:0042354) | 3.06891550 |
| 95 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05525915 |
| 96 | dendrite development (GO:0016358) | 3.05360173 |
| 97 | neuromuscular synaptic transmission (GO:0007274) | 3.05114884 |
| 98 | membrane depolarization (GO:0051899) | 3.04949388 |
| 99 | synapse organization (GO:0050808) | 3.03687794 |
| 100 | positive regulation of dendritic spine development (GO:0060999) | 3.02187427 |
| 101 | axon extension (GO:0048675) | 3.02094717 |
| 102 | regulation of neurotransmitter secretion (GO:0046928) | 3.00970004 |
| 103 | nonmotile primary cilium assembly (GO:0035058) | 3.00569017 |
| 104 | social behavior (GO:0035176) | 2.96817673 |
| 105 | intraspecies interaction between organisms (GO:0051703) | 2.96817673 |
| 106 | membrane hyperpolarization (GO:0060081) | 2.95966560 |
| 107 | fear response (GO:0042596) | 2.95788222 |
| 108 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.95276113 |
| 109 | action potential (GO:0001508) | 2.93632198 |
| 110 | retinal ganglion cell axon guidance (GO:0031290) | 2.93085387 |
| 111 | cerebellum development (GO:0021549) | 2.93013773 |
| 112 | dendritic spine organization (GO:0097061) | 2.91793024 |
| 113 | central nervous system neuron axonogenesis (GO:0021955) | 2.91286755 |
| 114 | regulation of neurotransmitter levels (GO:0001505) | 2.90021854 |
| 115 | vesicle transport along microtubule (GO:0047496) | 2.89305458 |
| 116 | neuromuscular process controlling balance (GO:0050885) | 2.89180000 |
| 117 | synaptic transmission, cholinergic (GO:0007271) | 2.86198670 |
| 118 | cellular ketone body metabolic process (GO:0046950) | 2.85174761 |
| 119 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.84331314 |
| 120 | atrial cardiac muscle cell action potential (GO:0086014) | 2.83044252 |
| 121 | urinary tract smooth muscle contraction (GO:0014848) | 2.78409760 |
| 122 | protein localization to cilium (GO:0061512) | 2.77730639 |
| 123 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.77410094 |
| 124 | detection of light stimulus involved in visual perception (GO:0050908) | 2.77410094 |
| 125 | positive regulation of action potential (GO:0045760) | 2.76695541 |
| 126 | reflex (GO:0060004) | 2.75706998 |
| 127 | indolalkylamine metabolic process (GO:0006586) | 2.72951896 |
| 128 | adult walking behavior (GO:0007628) | 2.71991702 |
| 129 | neuron maturation (GO:0042551) | 2.70702619 |
| 130 | adult behavior (GO:0030534) | 2.69089856 |
| 131 | tryptophan catabolic process (GO:0006569) | 2.67752791 |
| 132 | indole-containing compound catabolic process (GO:0042436) | 2.67752791 |
| 133 | indolalkylamine catabolic process (GO:0046218) | 2.67752791 |
| 134 | neurofilament cytoskeleton organization (GO:0060052) | 2.67289955 |
| 135 | indole-containing compound metabolic process (GO:0042430) | 2.65072514 |
| 136 | peristalsis (GO:0030432) | 2.64520751 |
| 137 | cAMP catabolic process (GO:0006198) | 2.63136236 |
| 138 | kynurenine metabolic process (GO:0070189) | 2.61530480 |
| 139 | spinal cord motor neuron differentiation (GO:0021522) | 2.59324670 |
| 140 | positive regulation of sodium ion transmembrane transporter activity (GO:2000651) | 2.56611812 |
| 141 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.55541933 |
| 142 | sulfation (GO:0051923) | 2.55410108 |
| 143 | ketone body metabolic process (GO:1902224) | 2.52944905 |
| 144 | epithelial cilium movement (GO:0003351) | 2.51805122 |
| 145 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.49939317 |
| 146 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.48629241 |
| 147 | neural tube formation (GO:0001841) | 2.48217384 |
| 148 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.45922768 |
| 149 | detection of mechanical stimulus involved in sensory perception (GO:0050974) | 2.42791695 |
| 150 | response to pheromone (GO:0019236) | 2.42360790 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.96384709 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.06460075 |
| 3 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.99667077 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99145335 |
| 5 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.87707242 |
| 6 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50457176 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.48544334 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.48270202 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.48270202 |
| 10 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.47562333 |
| 11 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.40331824 |
| 12 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37211359 |
| 13 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.33116737 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.31608209 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.29130904 |
| 16 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.21741060 |
| 17 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.21165691 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.19759162 |
| 19 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.15786087 |
| 20 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.14839390 |
| 21 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.14071103 |
| 22 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.12819683 |
| 23 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12268509 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.09648000 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.08161090 |
| 26 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.01529454 |
| 27 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.99163720 |
| 28 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.98961064 |
| 29 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.97832369 |
| 30 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.95329538 |
| 31 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.87355929 |
| 32 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.83216009 |
| 33 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.77928679 |
| 34 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.76675935 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.74261345 |
| 36 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.67753085 |
| 37 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.62018255 |
| 38 | EWS_26573619_Chip-Seq_HEK293_Human | 1.60366020 |
| 39 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.56671877 |
| 40 | FUS_26573619_Chip-Seq_HEK293_Human | 1.52114610 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.51726054 |
| 42 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.51169526 |
| 43 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50857799 |
| 44 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.50787961 |
| 45 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.50256010 |
| 46 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.48960729 |
| 47 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.48173234 |
| 48 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.47883528 |
| 49 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.46499435 |
| 50 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.43919581 |
| 51 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.41813205 |
| 52 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.41487097 |
| 53 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.40101972 |
| 54 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39668102 |
| 55 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38608788 |
| 56 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.38130374 |
| 57 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.38057117 |
| 58 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.35752017 |
| 59 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.35362248 |
| 60 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35334007 |
| 61 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.35252620 |
| 62 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.29757087 |
| 63 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29082361 |
| 64 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28966482 |
| 65 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.27744394 |
| 66 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.27744394 |
| 67 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.26137912 |
| 68 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.25494837 |
| 69 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25192422 |
| 70 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.24889086 |
| 71 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.24472477 |
| 72 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.23617995 |
| 73 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.22113832 |
| 74 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.18942781 |
| 75 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.17762752 |
| 76 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.17732916 |
| 77 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.17721970 |
| 78 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.17296015 |
| 79 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.17275178 |
| 80 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16334879 |
| 81 | TP53_16413492_ChIP-PET_HCT116_Human | 1.15503302 |
| 82 | * AR_19668381_ChIP-Seq_PC3_Human | 1.14950804 |
| 83 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.14925634 |
| 84 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.13975009 |
| 85 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13701608 |
| 86 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.13073252 |
| 87 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.12159172 |
| 88 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.12159172 |
| 89 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.11540115 |
| 90 | VDR_22108803_ChIP-Seq_LS180_Human | 1.10561012 |
| 91 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.08965365 |
| 92 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.08646575 |
| 93 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08616868 |
| 94 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.08462624 |
| 95 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.08099843 |
| 96 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07892304 |
| 97 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.06864094 |
| 98 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.06431049 |
| 99 | JUN_21703547_ChIP-Seq_K562_Human | 1.05695740 |
| 100 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.04006999 |
| 101 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.03587354 |
| 102 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.03244930 |
| 103 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.02597777 |
| 104 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 1.02475102 |
| 105 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.02300776 |
| 106 | * TP53_22573176_ChIP-Seq_HFKS_Human | 1.01729626 |
| 107 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00856664 |
| 108 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99844020 |
| 109 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99666918 |
| 110 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.99359983 |
| 111 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98930327 |
| 112 | ETV2_25802403_ChIP-Seq_MESCs_Mouse | 0.98753490 |
| 113 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.98529950 |
| 114 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.98150564 |
| 115 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.98150564 |
| 116 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.97674465 |
| 117 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.97533688 |
| 118 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.96662074 |
| 119 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 0.96435878 |
| 120 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.95429236 |
| 121 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.94091232 |
| 122 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92845985 |
| 123 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92646665 |
| 124 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.92608055 |
| 125 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.90992633 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.07485207 |
| 2 | MP0003880_abnormal_central_pattern | 4.58485793 |
| 3 | MP0004270_analgesia | 4.21402558 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 4.05901748 |
| 5 | MP0002063_abnormal_learning/memory/cond | 3.36628516 |
| 6 | MP0009745_abnormal_behavioral_response | 3.30529879 |
| 7 | MP0002064_seizures | 2.98519816 |
| 8 | MP0005423_abnormal_somatic_nervous | 2.98335025 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.85222538 |
| 10 | MP0002572_abnormal_emotion/affect_behav | 2.83858829 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.81868539 |
| 12 | MP0009046_muscle_twitch | 2.76553943 |
| 13 | MP0001486_abnormal_startle_reflex | 2.65824709 |
| 14 | MP0002735_abnormal_chemical_nociception | 2.49012350 |
| 15 | MP0002272_abnormal_nervous_system | 2.46948375 |
| 16 | MP0000778_abnormal_nervous_system | 2.43632883 |
| 17 | MP0001440_abnormal_grooming_behavior | 2.22850745 |
| 18 | MP0002733_abnormal_thermal_nociception | 2.16815439 |
| 19 | MP0001501_abnormal_sleep_pattern | 2.16157491 |
| 20 | MP0002736_abnormal_nociception_after | 2.13600293 |
| 21 | MP0003329_amyloid_beta_deposits | 2.08522194 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.04497041 |
| 23 | MP0002184_abnormal_innervation | 2.04081634 |
| 24 | MP0002067_abnormal_sensory_capabilities | 1.96754409 |
| 25 | MP0004924_abnormal_behavior | 1.96693233 |
| 26 | MP0005386_behavior/neurological_phenoty | 1.96693233 |
| 27 | MP0001529_abnormal_vocalization | 1.95986112 |
| 28 | MP0001970_abnormal_pain_threshold | 1.95843956 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 1.91672207 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.85620808 |
| 31 | MP0004811_abnormal_neuron_physiology | 1.74015606 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.68091019 |
| 33 | MP0002822_catalepsy | 1.65973334 |
| 34 | MP0004858_abnormal_nervous_system | 1.62356188 |
| 35 | MP0000955_abnormal_spinal_cord | 1.62291990 |
| 36 | MP0003195_calcinosis | 1.62204162 |
| 37 | MP0008569_lethality_at_weaning | 1.60942565 |
| 38 | MP0003787_abnormal_imprinting | 1.59262301 |
| 39 | MP0002882_abnormal_neuron_morphology | 1.51095296 |
| 40 | MP0001984_abnormal_olfaction | 1.50368418 |
| 41 | MP0005645_abnormal_hypothalamus_physiol | 1.49269477 |
| 42 | MP0006292_abnormal_olfactory_placode | 1.48305622 |
| 43 | MP0002909_abnormal_adrenal_gland | 1.47831583 |
| 44 | MP0002066_abnormal_motor_capabilities/c | 1.45327077 |
| 45 | MP0001188_hyperpigmentation | 1.44471211 |
| 46 | MP0001905_abnormal_dopamine_level | 1.43064601 |
| 47 | MP0004885_abnormal_endolymph | 1.42309781 |
| 48 | MP0004133_heterotaxia | 1.41737746 |
| 49 | MP0000569_abnormal_digit_pigmentation | 1.39336581 |
| 50 | MP0005646_abnormal_pituitary_gland | 1.34209424 |
| 51 | MP0003879_abnormal_hair_cell | 1.32568737 |
| 52 | MP0003121_genomic_imprinting | 1.28631536 |
| 53 | MP0003890_abnormal_embryonic-extraembry | 1.27636206 |
| 54 | MP0002152_abnormal_brain_morphology | 1.25079512 |
| 55 | MP0005409_darkened_coat_color | 1.21570179 |
| 56 | MP0004142_abnormal_muscle_tone | 1.19723512 |
| 57 | MP0003633_abnormal_nervous_system | 1.19635183 |
| 58 | MP0001986_abnormal_taste_sensitivity | 1.19502574 |
| 59 | MP0005253_abnormal_eye_physiology | 1.18847208 |
| 60 | MP0002653_abnormal_ependyma_morphology | 1.16044992 |
| 61 | MP0006072_abnormal_retinal_apoptosis | 1.13944496 |
| 62 | MP0004742_abnormal_vestibular_system | 1.12041631 |
| 63 | MP0003122_maternal_imprinting | 1.10014989 |
| 64 | MP0003631_nervous_system_phenotype | 1.09563784 |
| 65 | MP0002837_dystrophic_cardiac_calcinosis | 1.08290794 |
| 66 | MP0000631_abnormal_neuroendocrine_gland | 1.06822471 |
| 67 | MP0002876_abnormal_thyroid_physiology | 1.06500188 |
| 68 | MP0004043_abnormal_pH_regulation | 1.05640537 |
| 69 | MP0003119_abnormal_digestive_system | 1.04368066 |
| 70 | MP0001502_abnormal_circadian_rhythm | 1.03628755 |
| 71 | MP0000920_abnormal_myelination | 1.03582160 |
| 72 | MP0003283_abnormal_digestive_organ | 1.02931706 |
| 73 | MP0010386_abnormal_urinary_bladder | 1.01863341 |
| 74 | MP0002229_neurodegeneration | 1.00598083 |
| 75 | MP0003136_yellow_coat_color | 0.98908195 |
| 76 | MP0005551_abnormal_eye_electrophysiolog | 0.98549295 |
| 77 | MP0005195_abnormal_posterior_eye | 0.98364619 |
| 78 | MP0002751_abnormal_autonomic_nervous | 0.98253002 |
| 79 | MP0003634_abnormal_glial_cell | 0.97824472 |
| 80 | MP0002234_abnormal_pharynx_morphology | 0.97354613 |
| 81 | MP0004145_abnormal_muscle_electrophysio | 0.95848895 |
| 82 | MP0003646_muscle_fatigue | 0.94513461 |
| 83 | MP0000604_amyloidosis | 0.93747572 |
| 84 | MP0003011_delayed_dark_adaptation | 0.92551769 |
| 85 | MP0002938_white_spotting | 0.91943125 |
| 86 | MP0002069_abnormal_eating/drinking_beha | 0.91127044 |
| 87 | MP0001963_abnormal_hearing_physiology | 0.91052561 |
| 88 | MP0003632_abnormal_nervous_system | 0.89379367 |
| 89 | MP0002752_abnormal_somatic_nervous | 0.88584351 |
| 90 | MP0002928_abnormal_bile_duct | 0.88082748 |
| 91 | MP0004085_abnormal_heartbeat | 0.86964385 |
| 92 | MP0000427_abnormal_hair_cycle | 0.86093924 |
| 93 | MP0005084_abnormal_gallbladder_morpholo | 0.83600169 |
| 94 | MP0005174_abnormal_tail_pigmentation | 0.83248406 |
| 95 | MP0005499_abnormal_olfactory_system | 0.82018726 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.82018726 |
| 97 | MP0001177_atelectasis | 0.81993023 |
| 98 | MP0005187_abnormal_penis_morphology | 0.81127134 |
| 99 | MP0008789_abnormal_olfactory_epithelium | 0.80594418 |
| 100 | MP0002160_abnormal_reproductive_system | 0.79165694 |
| 101 | MP0003137_abnormal_impulse_conducting | 0.77985916 |
| 102 | MP0003861_abnormal_nervous_system | 0.77589600 |
| 103 | MP0001348_abnormal_lacrimal_gland | 0.75047504 |
| 104 | MP0000566_synostosis | 0.74618104 |
| 105 | MP0004130_abnormal_muscle_cell | 0.74402030 |
| 106 | MP0008874_decreased_physiological_sensi | 0.74272648 |
| 107 | MP0004147_increased_porphyrin_level | 0.73786550 |
| 108 | MP0008872_abnormal_physiological_respon | 0.73281243 |
| 109 | MP0000751_myopathy | 0.72502844 |
| 110 | MP0001299_abnormal_eye_distance/ | 0.71176196 |
| 111 | MP0003690_abnormal_glial_cell | 0.69707996 |
| 112 | MP0005535_abnormal_body_temperature | 0.69070976 |
| 113 | MP0001485_abnormal_pinna_reflex | 0.67117694 |
| 114 | MP0000026_abnormal_inner_ear | 0.66537602 |
| 115 | MP0004215_abnormal_myocardial_fiber | 0.62677906 |
| 116 | MP0004233_abnormal_muscle_weight | 0.61076028 |
| 117 | MP0004484_altered_response_of | 0.60021563 |
| 118 | MP0001943_abnormal_respiration | 0.59082884 |
| 119 | MP0002102_abnormal_ear_morphology | 0.58842623 |
| 120 | MP0001664_abnormal_digestion | 0.58249726 |
| 121 | MP0003938_abnormal_ear_development | 0.57626434 |
| 122 | MP0002638_abnormal_pupillary_reflex | 0.56011383 |
| 123 | MP0000013_abnormal_adipose_tissue | 0.55956394 |
| 124 | MP0004510_myositis | 0.54903669 |
| 125 | MP0005171_absent_coat_pigmentation | 0.54646644 |
| 126 | MP0010770_preweaning_lethality | 0.54536231 |
| 127 | MP0002082_postnatal_lethality | 0.54536231 |
| 128 | MP0010769_abnormal_survival | 0.54172252 |
| 129 | MP0002090_abnormal_vision | 0.53320007 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.02700822 |
| 2 | Focal seizures (HP:0007359) | 5.47626183 |
| 3 | Myokymia (HP:0002411) | 5.43249230 |
| 4 | Epileptic encephalopathy (HP:0200134) | 4.83906414 |
| 5 | Visual hallucinations (HP:0002367) | 4.68148621 |
| 6 | Atonic seizures (HP:0010819) | 4.28555927 |
| 7 | Hyperventilation (HP:0002883) | 4.27260374 |
| 8 | Absence seizures (HP:0002121) | 4.17187126 |
| 9 | Progressive cerebellar ataxia (HP:0002073) | 4.12055814 |
| 10 | Broad-based gait (HP:0002136) | 3.94330473 |
| 11 | Febrile seizures (HP:0002373) | 3.80292657 |
| 12 | Dialeptic seizures (HP:0011146) | 3.80062727 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.73173249 |
| 14 | Abnormality of the corticospinal tract (HP:0002492) | 3.72032835 |
| 15 | Pancreatic cysts (HP:0001737) | 3.69636622 |
| 16 | Excessive salivation (HP:0003781) | 3.66362255 |
| 17 | Drooling (HP:0002307) | 3.66362255 |
| 18 | Molar tooth sign on MRI (HP:0002419) | 3.65592181 |
| 19 | Abnormality of midbrain morphology (HP:0002418) | 3.65592181 |
| 20 | Generalized tonic-clonic seizures (HP:0002069) | 3.58565848 |
| 21 | Neurofibrillary tangles (HP:0002185) | 3.57844998 |
| 22 | Congenital stationary night blindness (HP:0007642) | 3.57350708 |
| 23 | Cerebral inclusion bodies (HP:0100314) | 3.56518181 |
| 24 | Poor eye contact (HP:0000817) | 3.55807470 |
| 25 | Pancreatic fibrosis (HP:0100732) | 3.49741293 |
| 26 | Mutism (HP:0002300) | 3.49731894 |
| 27 | True hermaphroditism (HP:0010459) | 3.46653058 |
| 28 | Nephronophthisis (HP:0000090) | 3.42124953 |
| 29 | Termporal pattern (HP:0011008) | 3.40746149 |
| 30 | Insidious onset (HP:0003587) | 3.40746149 |
| 31 | Truncal ataxia (HP:0002078) | 3.36178183 |
| 32 | Action tremor (HP:0002345) | 3.31604664 |
| 33 | Amyotrophic lateral sclerosis (HP:0007354) | 3.17130449 |
| 34 | Abnormal social behavior (HP:0012433) | 3.16747092 |
| 35 | Impaired social interactions (HP:0000735) | 3.16747092 |
| 36 | Ankle clonus (HP:0011448) | 3.11048393 |
| 37 | Papilledema (HP:0001085) | 3.06490670 |
| 38 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.99244574 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.97480115 |
| 40 | Epileptiform EEG discharges (HP:0011182) | 2.92474867 |
| 41 | Progressive inability to walk (HP:0002505) | 2.91634268 |
| 42 | Akinesia (HP:0002304) | 2.91049202 |
| 43 | Abnormality of the renal medulla (HP:0100957) | 2.88913474 |
| 44 | Gaze-evoked nystagmus (HP:0000640) | 2.87923271 |
| 45 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.87369320 |
| 46 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.87369320 |
| 47 | Inappropriate behavior (HP:0000719) | 2.82404172 |
| 48 | Limb dystonia (HP:0002451) | 2.80903983 |
| 49 | EEG with generalized epileptiform discharges (HP:0011198) | 2.79356870 |
| 50 | Spastic gait (HP:0002064) | 2.76765486 |
| 51 | Medial flaring of the eyebrow (HP:0010747) | 2.76297627 |
| 52 | Polyphagia (HP:0002591) | 2.76162124 |
| 53 | Absent speech (HP:0001344) | 2.75495410 |
| 54 | Dysmetria (HP:0001310) | 2.72854384 |
| 55 | Dysdiadochokinesis (HP:0002075) | 2.72116969 |
| 56 | Diplopia (HP:0000651) | 2.72015672 |
| 57 | Abnormality of binocular vision (HP:0011514) | 2.72015672 |
| 58 | Genetic anticipation (HP:0003743) | 2.70029439 |
| 59 | Amblyopia (HP:0000646) | 2.68979812 |
| 60 | Inability to walk (HP:0002540) | 2.67811125 |
| 61 | Urinary urgency (HP:0000012) | 2.67339081 |
| 62 | Abnormal eating behavior (HP:0100738) | 2.65090441 |
| 63 | Hypsarrhythmia (HP:0002521) | 2.64183594 |
| 64 | Depression (HP:0000716) | 2.63714947 |
| 65 | Abnormality of the renal cortex (HP:0011035) | 2.60083548 |
| 66 | Abolished electroretinogram (ERG) (HP:0000550) | 2.58163110 |
| 67 | Abnormality of salivation (HP:0100755) | 2.57107811 |
| 68 | Fetal akinesia sequence (HP:0001989) | 2.52050463 |
| 69 | Chronic hepatic failure (HP:0100626) | 2.51814714 |
| 70 | Anxiety (HP:0000739) | 2.51598729 |
| 71 | Type II lissencephaly (HP:0007260) | 2.49217676 |
| 72 | Pendular nystagmus (HP:0012043) | 2.46316060 |
| 73 | Attenuation of retinal blood vessels (HP:0007843) | 2.42017503 |
| 74 | Cystic liver disease (HP:0006706) | 2.41361939 |
| 75 | Protruding tongue (HP:0010808) | 2.40829721 |
| 76 | Hemiparesis (HP:0001269) | 2.38751962 |
| 77 | Generalized myoclonic seizures (HP:0002123) | 2.38121779 |
| 78 | Scanning speech (HP:0002168) | 2.37604184 |
| 79 | Impaired smooth pursuit (HP:0007772) | 2.35582815 |
| 80 | Stereotypic behavior (HP:0000733) | 2.35393491 |
| 81 | Hypothermia (HP:0002045) | 2.34573158 |
| 82 | Congenital primary aphakia (HP:0007707) | 2.34211809 |
| 83 | Blue irides (HP:0000635) | 2.31877288 |
| 84 | Keratoconus (HP:0000563) | 2.30958650 |
| 85 | Increased corneal curvature (HP:0100692) | 2.30958650 |
| 86 | Absent/shortened dynein arms (HP:0200106) | 2.30377513 |
| 87 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.30377513 |
| 88 | Gait imbalance (HP:0002141) | 2.29454804 |
| 89 | Agitation (HP:0000713) | 2.29337722 |
| 90 | Nephrogenic diabetes insipidus (HP:0009806) | 2.29046059 |
| 91 | Bony spicule pigmentary retinopathy (HP:0007737) | 2.27458546 |
| 92 | Pachygyria (HP:0001302) | 2.27384137 |
| 93 | Sclerocornea (HP:0000647) | 2.25124705 |
| 94 | Postural instability (HP:0002172) | 2.24280268 |
| 95 | Intention tremor (HP:0002080) | 2.22962170 |
| 96 | Lower limb muscle weakness (HP:0007340) | 2.21203100 |
| 97 | Congenital sensorineural hearing impairment (HP:0008527) | 2.19355092 |
| 98 | Genital tract atresia (HP:0001827) | 2.19342211 |
| 99 | Vaginal atresia (HP:0000148) | 2.18243732 |
| 100 | Megalencephaly (HP:0001355) | 2.18201129 |
| 101 | Aqueductal stenosis (HP:0002410) | 2.15452147 |
| 102 | Chorioretinal atrophy (HP:0000533) | 2.14494859 |
| 103 | Torticollis (HP:0000473) | 2.13932131 |
| 104 | Abnormality of the lower motor neuron (HP:0002366) | 2.12886837 |
| 105 | Abnormal drinking behavior (HP:0030082) | 2.11007800 |
| 106 | Polydipsia (HP:0001959) | 2.11007800 |
| 107 | Anencephaly (HP:0002323) | 2.09533293 |
| 108 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.08961197 |
| 109 | Decreased central vision (HP:0007663) | 2.05712309 |
| 110 | Concave nail (HP:0001598) | 2.05194139 |
| 111 | Pheochromocytoma (HP:0002666) | 2.03007349 |
| 112 | Generalized hypopigmentation of hair (HP:0011358) | 2.02535148 |
| 113 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.02226309 |
| 114 | Widely spaced teeth (HP:0000687) | 2.00165643 |
| 115 | Bradykinesia (HP:0002067) | 1.99967978 |
| 116 | Furrowed tongue (HP:0000221) | 1.99654102 |
| 117 | Large for gestational age (HP:0001520) | 1.99527447 |
| 118 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99133388 |
| 119 | Congenital, generalized hypertrichosis (HP:0004540) | 1.98884950 |
| 120 | Hypoplasia of the brainstem (HP:0002365) | 1.98760631 |
| 121 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.98760631 |
| 122 | Impaired vibratory sensation (HP:0002495) | 1.97148467 |
| 123 | Exotropia (HP:0000577) | 1.97135828 |
| 124 | Abnormality of alanine metabolism (HP:0010916) | 1.94119157 |
| 125 | Hyperalaninemia (HP:0003348) | 1.94119157 |
| 126 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.94119157 |
| 127 | Renal cortical cysts (HP:0000803) | 1.93275279 |
| 128 | Focal dystonia (HP:0004373) | 1.93001377 |
| 129 | Optic nerve hypoplasia (HP:0000609) | 1.92711315 |
| 130 | Obstructive sleep apnea (HP:0002870) | 1.91516389 |
| 131 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.90788071 |
| 132 | Abnormality of the labia minora (HP:0012880) | 1.89762961 |
| 133 | Decreased circulating renin level (HP:0003351) | 1.88384008 |
| 134 | Apathy (HP:0000741) | 1.87941168 |
| 135 | Fair hair (HP:0002286) | 1.87216580 |
| 136 | Specific learning disability (HP:0001328) | 1.86940948 |
| 137 | Gastroesophageal reflux (HP:0002020) | 1.86481999 |
| 138 | Poor coordination (HP:0002370) | 1.84774608 |
| 139 | Lissencephaly (HP:0001339) | 1.84235661 |
| 140 | Neuronal loss in central nervous system (HP:0002529) | 1.83789572 |
| 141 | Retinal dysplasia (HP:0007973) | 1.83292377 |
| 142 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.82967119 |
| 143 | Congenital hepatic fibrosis (HP:0002612) | 1.82822966 |
| 144 | Oligodactyly (hands) (HP:0001180) | 1.82726329 |
| 145 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.82689309 |
| 146 | Male pseudohermaphroditism (HP:0000037) | 1.82417066 |
| 147 | Tubular atrophy (HP:0000092) | 1.82205310 |
| 148 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.82086821 |
| 149 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.82086821 |
| 150 | Hyperthyroidism (HP:0000836) | 1.81136337 |
| 151 | Lower limb amyotrophy (HP:0007210) | 1.81107028 |
| 152 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.80422684 |
| 153 | Sporadic (HP:0003745) | 1.79809146 |
| 154 | Narrow forehead (HP:0000341) | 1.79735445 |
| 155 | Patellar aplasia (HP:0006443) | 1.76400891 |
| 156 | Abnormal ciliary motility (HP:0012262) | 1.75575126 |
| 157 | Prolonged QT interval (HP:0001657) | 1.75296552 |
| 158 | Gait ataxia (HP:0002066) | 1.75096930 |
| 159 | Clumsiness (HP:0002312) | 1.74588902 |
| 160 | Psychosis (HP:0000709) | 1.74511649 |
| 161 | Thickened helices (HP:0000391) | 1.73661866 |
| 162 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.69800605 |
| 163 | Aplasia/Hypoplasia of the patella (HP:0006498) | 1.68255126 |
| 164 | Postaxial foot polydactyly (HP:0001830) | 1.68011096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MARK1 | 5.64439938 |
| 2 | FRK | 3.99505115 |
| 3 | NTRK3 | 3.96948266 |
| 4 | MAP3K9 | 3.46425680 |
| 5 | EPHA4 | 3.26857393 |
| 6 | MAP3K4 | 3.21861567 |
| 7 | MAP2K7 | 2.72111936 |
| 8 | CASK | 2.71167563 |
| 9 | MINK1 | 2.63065533 |
| 10 | ADRBK2 | 2.60062732 |
| 11 | NTRK2 | 2.34890633 |
| 12 | PAK6 | 1.91482345 |
| 13 | NTRK1 | 1.89458023 |
| 14 | MAPK13 | 1.87320225 |
| 15 | DAPK2 | 1.86558169 |
| 16 | TNIK | 1.84857961 |
| 17 | INSRR | 1.84751723 |
| 18 | PNCK | 1.80869701 |
| 19 | SIK2 | 1.78106372 |
| 20 | KSR1 | 1.76561117 |
| 21 | MAP2K4 | 1.73067715 |
| 22 | GRK1 | 1.70986039 |
| 23 | PINK1 | 1.65856576 |
| 24 | RIPK4 | 1.62932638 |
| 25 | MAP3K12 | 1.61635538 |
| 26 | PLK2 | 1.57897656 |
| 27 | WNK4 | 1.56839147 |
| 28 | CDK5 | 1.51288560 |
| 29 | PHKG2 | 1.50308393 |
| 30 | PHKG1 | 1.50308393 |
| 31 | MAP4K2 | 1.49028802 |
| 32 | DYRK2 | 1.42877679 |
| 33 | ACVR1B | 1.41798079 |
| 34 | TLK1 | 1.39512745 |
| 35 | KSR2 | 1.34349909 |
| 36 | ERBB3 | 1.33629135 |
| 37 | DAPK1 | 1.25938337 |
| 38 | ZAK | 1.25674640 |
| 39 | PRPF4B | 1.18984982 |
| 40 | LATS2 | 1.18651128 |
| 41 | GRK5 | 1.14806278 |
| 42 | PRKCG | 1.14786127 |
| 43 | UHMK1 | 1.13556177 |
| 44 | CSNK1G2 | 1.12074267 |
| 45 | NUAK1 | 1.11758962 |
| 46 | MAP3K2 | 1.10845392 |
| 47 | CAMK2A | 1.08792960 |
| 48 | CAMKK1 | 1.07867966 |
| 49 | CDK19 | 1.05653814 |
| 50 | ADRBK1 | 1.01880749 |
| 51 | MKNK2 | 0.99740596 |
| 52 | WNK3 | 0.99185039 |
| 53 | CAMK2B | 0.98196630 |
| 54 | PAK3 | 0.96851880 |
| 55 | BCR | 0.92921581 |
| 56 | PKN1 | 0.90842207 |
| 57 | TAOK3 | 0.90765572 |
| 58 | OXSR1 | 0.89403462 |
| 59 | DYRK1A | 0.88781870 |
| 60 | PRKD3 | 0.86767556 |
| 61 | CDK14 | 0.86756813 |
| 62 | BMPR2 | 0.86661722 |
| 63 | CDK18 | 0.85921078 |
| 64 | TRIM28 | 0.84295027 |
| 65 | CDK15 | 0.82986223 |
| 66 | FES | 0.81639699 |
| 67 | RET | 0.80071406 |
| 68 | MARK2 | 0.76377185 |
| 69 | CSNK1G1 | 0.76102933 |
| 70 | STK11 | 0.74466125 |
| 71 | MAP3K6 | 0.74399282 |
| 72 | FGFR2 | 0.73346770 |
| 73 | EPHA3 | 0.72680908 |
| 74 | SGK223 | 0.71984559 |
| 75 | SGK494 | 0.71984559 |
| 76 | CDK11A | 0.71477212 |
| 77 | CAMKK2 | 0.71115105 |
| 78 | CCNB1 | 0.71017977 |
| 79 | MAPK15 | 0.69753464 |
| 80 | TYRO3 | 0.69507144 |
| 81 | PRKCE | 0.68573742 |
| 82 | SGK1 | 0.67419317 |
| 83 | TAF1 | 0.65393287 |
| 84 | FGR | 0.65360936 |
| 85 | DYRK3 | 0.64750617 |
| 86 | CAMK1G | 0.62949148 |
| 87 | CAMK1 | 0.60492472 |
| 88 | SCYL2 | 0.60177318 |
| 89 | STK39 | 0.59867670 |
| 90 | CSNK1G3 | 0.59576682 |
| 91 | TIE1 | 0.59321132 |
| 92 | PIK3CA | 0.58623480 |
| 93 | PRKCZ | 0.56690346 |
| 94 | CSNK1A1L | 0.56066273 |
| 95 | PRKACA | 0.54799175 |
| 96 | RAF1 | 0.54682293 |
| 97 | CAMK2D | 0.52328515 |
| 98 | STK38 | 0.50844223 |
| 99 | ARAF | 0.50633787 |
| 100 | FYN | 0.50561366 |
| 101 | FER | 0.50384805 |
| 102 | CAMK4 | 0.50334862 |
| 103 | GRK7 | 0.49955662 |
| 104 | SGK2 | 0.49590231 |
| 105 | MUSK | 0.49526739 |
| 106 | SIK3 | 0.48241588 |
| 107 | PTK2B | 0.47864140 |
| 108 | PRKCH | 0.46300332 |
| 109 | MAPK12 | 0.46214335 |
| 110 | NME1 | 0.45846454 |
| 111 | TGFBR1 | 0.43675611 |
| 112 | EPHB2 | 0.43622709 |
| 113 | CSNK1D | 0.43512482 |
| 114 | TXK | 0.43334055 |
| 115 | TAOK1 | 0.42178653 |
| 116 | ROCK2 | 0.41275708 |
| 117 | ALK | 0.41133481 |
| 118 | RPS6KA3 | 0.40293355 |
| 119 | MAPKAPK5 | 0.40061831 |
| 120 | ERBB2 | 0.38815164 |
| 121 | RPS6KA2 | 0.37759122 |
| 122 | MAPK10 | 0.36749238 |
| 123 | AKT3 | 0.36738808 |
| 124 | VRK1 | 0.36041446 |
| 125 | MAP2K1 | 0.35890781 |
| 126 | PDPK1 | 0.35819480 |
| 127 | CSNK1A1 | 0.35629016 |
| 128 | BMPR1B | 0.34931516 |
| 129 | PRKG1 | 0.34804933 |
| 130 | PRKACB | 0.34740555 |
| 131 | PDK1 | 0.34677446 |
| 132 | NEK6 | 0.34543011 |
| 133 | CSNK1E | 0.34118542 |
| 134 | PRKAA1 | 0.33972685 |
| 135 | PRKCA | 0.33473770 |
| 136 | SGK3 | 0.32719585 |
| 137 | CAMK2G | 0.32353840 |
| 138 | WNK1 | 0.31722747 |
| 139 | CDK3 | 0.31197099 |
| 140 | MAP2K6 | 0.30811732 |
| 141 | PRKCQ | 0.30161203 |
| 142 | PRKCB | 0.28701727 |
| 143 | RPS6KA5 | 0.28267927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.99146291 |
| 2 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.82918860 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.74833531 |
| 4 | Circadian entrainment_Homo sapiens_hsa04713 | 2.72537280 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.71512293 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.71325014 |
| 7 | Long-term potentiation_Homo sapiens_hsa04720 | 2.67873550 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.50724378 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.37438015 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.33075087 |
| 11 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.25983589 |
| 12 | Salivary secretion_Homo sapiens_hsa04970 | 2.10073427 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.04772239 |
| 14 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.04033854 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.96057053 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 1.95654075 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.94396895 |
| 18 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.90795569 |
| 19 | Long-term depression_Homo sapiens_hsa04730 | 1.83818705 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.80424199 |
| 21 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.80234712 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.76836066 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.75247975 |
| 24 | Axon guidance_Homo sapiens_hsa04360 | 1.70836555 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69277824 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.68386764 |
| 27 | Parkinsons disease_Homo sapiens_hsa05012 | 1.67395096 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.64094511 |
| 29 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.61666045 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.61256579 |
| 31 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53553666 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.50192564 |
| 33 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44282748 |
| 34 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.44095929 |
| 35 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.42095487 |
| 36 | Gap junction_Homo sapiens_hsa04540 | 1.40136878 |
| 37 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.31279674 |
| 38 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.27738930 |
| 39 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.23088505 |
| 40 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.23037229 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.22065873 |
| 42 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.20805056 |
| 43 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.19692931 |
| 44 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.17639620 |
| 45 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.15961097 |
| 46 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.14813945 |
| 47 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.13592801 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 1.08730404 |
| 49 | Melanogenesis_Homo sapiens_hsa04916 | 1.07824237 |
| 50 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.06972457 |
| 51 | Huntingtons disease_Homo sapiens_hsa05016 | 1.06597781 |
| 52 | Protein export_Homo sapiens_hsa03060 | 1.04762491 |
| 53 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.02676681 |
| 54 | Glioma_Homo sapiens_hsa05214 | 1.02385745 |
| 55 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.02243178 |
| 56 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.99280660 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.97493229 |
| 58 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.92382106 |
| 59 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91904772 |
| 60 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90744223 |
| 61 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.90698232 |
| 62 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.88189076 |
| 63 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87340898 |
| 64 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.86663955 |
| 65 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.85859250 |
| 66 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81896469 |
| 67 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.81005119 |
| 68 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.78560401 |
| 69 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77907873 |
| 70 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.77869394 |
| 71 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77282499 |
| 72 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.77189453 |
| 73 | ABC transporters_Homo sapiens_hsa02010 | 0.77143941 |
| 74 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76382164 |
| 75 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.76369829 |
| 76 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.75941465 |
| 77 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.75358470 |
| 78 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.71222747 |
| 79 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.71177749 |
| 80 | Basal transcription factors_Homo sapiens_hsa03022 | 0.70359510 |
| 81 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.69872747 |
| 82 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.67037825 |
| 83 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63825637 |
| 84 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.63633164 |
| 85 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63421700 |
| 86 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.61570916 |
| 87 | Peroxisome_Homo sapiens_hsa04146 | 0.61339851 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.60523844 |
| 89 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.60242075 |
| 90 | Alcoholism_Homo sapiens_hsa05034 | 0.60097656 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.59984157 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.57035762 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.56986307 |
| 94 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.56963285 |
| 95 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.56362336 |
| 96 | Alzheimers disease_Homo sapiens_hsa05010 | 0.55528112 |
| 97 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.55234042 |
| 98 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.54847909 |
| 99 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.54724783 |
| 100 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54660393 |
| 101 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53685487 |
| 102 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53541283 |
| 103 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.52202239 |
| 104 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.49628443 |
| 105 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.49169354 |
| 106 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.49133671 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.48930101 |
| 108 | Colorectal cancer_Homo sapiens_hsa05210 | 0.47227192 |
| 109 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.46629366 |
| 110 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.46579135 |
| 111 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45551137 |
| 112 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.44981493 |
| 113 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.44743461 |
| 114 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.44717482 |
| 115 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.44580657 |
| 116 | Prion diseases_Homo sapiens_hsa05020 | 0.44549093 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.41936952 |
| 118 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.40548347 |
| 119 | RNA polymerase_Homo sapiens_hsa03020 | 0.39750975 |
| 120 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39672616 |
| 121 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.39441263 |
| 122 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.38844003 |
| 123 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.38471839 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.37930850 |
| 125 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.37863524 |
| 126 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37573827 |
| 127 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37194543 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.37174947 |
| 129 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.37028004 |
| 130 | Endocytosis_Homo sapiens_hsa04144 | 0.36794345 |
| 131 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.33991845 |
| 132 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.33213330 |
| 133 | Mineral absorption_Homo sapiens_hsa04978 | 0.31493803 |
| 134 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.30604488 |
| 135 | Bile secretion_Homo sapiens_hsa04976 | 0.30090758 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29934720 |
| 137 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.29800199 |
| 138 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.28710993 |
| 139 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.28704560 |
| 140 | Circadian rhythm_Homo sapiens_hsa04710 | 0.28066753 |
| 141 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.26213534 |

